Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy and Radiation in Pediatric Hodgkin's Disease
NCT00592111Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Mar 1996
- Primary completion
- Feb 1999
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin in Hodgkin lymphoma (HL), sponsored by Memorial Sloan Kettering Cancer Center. Started Mar 1996; status: completed.
02
Drugs
cyclophosphamidevincristineprocarbazineprednisonedoxorubicin
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00592111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00592111.